Tema Oncology ETF
Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
CANC price
Table
| Date | CANC close |
|---|---|
| Oct 16, 2026 | $39.65 |
| Oct 19, 2026 | $40.01 |
| Oct 20, 2026 | $41.59 |
| Oct 21, 2026 | $41.53 |
| Oct 22, 2026 | $41.50 |
| Oct 23, 2026 | $41.29 |
| Oct 26, 2026 | $40.99 |
| Oct 27, 2026 | $41.75 |
| Oct 28, 2026 | $42.60 |
| Oct 29, 2026 | $42.35 |
| Oct 30, 2026 | $42.29 |
| Nov 2, 2026 | $41.67 |
| Nov 3, 2026 | $42.10 |
| Nov 4, 2026 | $42.89 |
| Nov 5, 2026 | $40.78 |
| Nov 6, 2026 | $41.85 |
| Nov 9, 2026 | $43.37 |
| Nov 10, 2026 | $42.68 |
| Nov 11, 2026 | $42.29 |
| Nov 12, 2026 | $41.21 |
| Nov 13, 2026 | $41.06 |
| Nov 16, 2026 | $40.26 |
Recent fund-flow records are unavailable, while the price has returned +16.0% so far this year. At 0.99% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GMABGENMAB A | 5.82% | $51.57 | +0.4% | ||
| 2 | LLYELI LILLY | 5.62% | $1431.67 | -0.8% | ||
| 3 | RVMDREVOLUTION MEDICINES | 5.34% | $166.87 | -3.1% | ||
| 4 | MRKMERCK & CO | 5.03% | $144.46 | -2.2% | ||
| 5 | ONCBeiGene | 4.34% | $411.29 | -1.3% | ||
| 6 | COGTCOGENT BIOSCIENCES | 4.31% | $27.44 | -3.9% | ||
| 7 | ABBVABBVIE | 3.88% | $294.55 | -0.2% | ||
| 8 | EXELEXELIXIS | 3.74% | $67.10 | -2.8% | ||
| 9 | CGONCG ONCOLOGY INC | 2.89% | $84.78 | +14.0% | ||
| 10 | BBIOBRIDGEBIO PHARMA | 3.20% | $77.36 | -1.2% | ||
| 11 | HALOHALOZYME THERAPEUTICS | 3.02% | $96.50 | -3.8% | ||
| 12 | BMYBRISTOL MYERS SQUIBB | 2.79% | $62.93 | -0.8% | ||
| 13 | ELVNENLIVEN THERAPEUTICS | 2.76% | $47.62 | -2.4% | ||
| 14 | JNJJOHNSON & JOHNSON | 2.41% | $282.55 | -1.1% | ||
| 15 | IDYAIDEAYA BIOSCIENCES | 2.27% | $30.36 | -4.6% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 56Sector weights
- Healthcare100%
- Health Technology88.87%
- Health Services8.46%
- Other4.09%
- Technology Services1.59%
- Mutual fund1.06%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 88.87% |
| Health Services | 8.46% |
| Other | 4.09% |
| Technology Services | 1.59% |
| Mutual fund | 1.06% |
Country weights
- United States82.49%
- Switzerland7.31%
- Japan6.83%
- Denmark5.94%
- United Kingdom2.34%
- China1.92%
- Germany1.5%
- Netherlands1.37%
Show as table
| Item | Value (%) |
|---|---|
| United States | 82.49% |
| Switzerland | 7.31% |
| Japan | 6.83% |
| Denmark | 5.94% |
| United Kingdom | 2.34% |
| China | 1.92% |
| Germany | 1.5% |
| Netherlands | 1.37% |
| 1 week | -5.7% |
| 1 month | +1.5% |
| 3 months | -5.6% |
| 6 months | +8.6% |
| YTD | +16.0% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 5.8% of the book; the top ten carry 45%. Spread across 56+ names, it behaves like roughly 32 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK